2025³â 08¿ù 08ÀÏ ±Ý¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92587°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



¡®±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡¡¯ ¸ðÁý¡¦ÀÏ±Þ 100¸¸¿ø

ÀâÄÚ¸®¾Æx¾Ë¹Ù¸óxǪ¶ó´ß º¹³¯ ÀÌ»ö¾Ë¹Ù
ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸ó(´ëÇ¥ÀÌ»ç À±ÇöÁØ)ÀÌ º¹³¯À» ¸Â¾Æ ġŲ Àü¹® ºê·£µå Ǫ¶ó´ß ġŲ°ú ÇÔ²² ÀÌ»ö ¾Ë¹Ù¸¦ ¸ðÁýÇÏ´Â À̺¥Æ®¸¦ ÁøÇàÇÑ´Ù°í 21ÀÏ ¹àÇû´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ³»´Þ 3ÀϱîÁö Ǫ¶ó´ß ġŲ°ú Çù¾÷ÇØ º¹³¯ ±â³ä ÀÌ»ö °ø°í¸¦ ³»°í ‘±ñdzġŲ »À ¹Ù¸¦ ¾Ë¹Ù¸ó’°ú ‘±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡’¸¦ ¸ðÁýÇÑ´Ù. À̹ø À̺¥Æ®´Â ¾Ë¹Ù¸óÀÌ ÁøÇà ÁßÀÎ ´ë±Ô¸ð ÇÁ·Î¸ð¼Ç ‘2025 ¿©¸§ ¾Ë¹Ù Æä½ºÅ¸(¿©¾ËÆä)’ÀÇ ÀÏȯÀÌ´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ¿©¸§Ã¶ ¹«´õÀ§¿Í ²ß²ßÇÑ ³¯¾¾·Î ÁöÃÄ ÀÖ´Â ±¸Á÷ÀÚµéÀ» À§ ...

GS25 ¡®»ý°úÀÏ ½º¹«µð¡¯ ¿î¿µÁ¡ ±âÁØ Àüü ÆÇ¸Å·® 3À§

2030 ¼¼´ë°¡ °í°´ 69.5%
GS25°¡ ¾÷°è ÃÖÃÊ·Î ¼±º¸ÀÎ »ý°úÀÏ ½º¹«µð Àü¿ë ±â±â GS¸®Å×ÀÏÀÌ ¿î¿µÇÏ´Â ÆíÀÇÁ¡ GS25°¡ º»°ÝÀûÀÎ ¹«´õÀ§¸¦ ¸Â¾Æ ÃÖ±Ù 2ÁÖ°£(6/23~7/6) ‘»ý°úÀÏ ½º¹«µð’ ¿î¿µ Á¡Æ÷ 20¿© °÷À» ´ë»óÀ¸·Î ÆÇ¸Å µ¥ÀÌÅ͸¦ ºÐ¼®ÇÑ °á°ú »ý°úÀÏ ½º¹«µð°¡ ‘Ä«Æä25 ¾Æ¸Þ¸®Ä«³ë’, ‘ÄÅ ¾óÀ½’¿¡ À̾î Àüü ÆÇ¸Å·® 3À§(´ã¹è Á¦¿Ü)¿¡ µî±ØÇÑ °ÍÀ¸·Î ºÐ¼®µÆ´Ù. GS25´Â Áö³­ÇØ 12¿ù ÆíÀÇÁ¡ ¾÷°è ÃÖÃÊ·Î Á÷¿µÁ¡ ÇѰ÷À» ÅëÇØ Áï¼® »ý°úÀÏ ½º¹«µð¸¦ ¼±º¸¿´´Ù. ÃֽŠ¸Ô°Å¸® Æ®·»µå¸¦ ¼±Á¡ÇϰíÀÚ ÆíÀÇÁ¡ Ư¼º¿¡ ¸Â´Â Àü¿ë ±â±â ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
±º»ê½Ã, ¿¹¼ú¡¤ÄÜÅÙÃ÷ ½ºÅ×ÀÌ¼Ç Ã¢¾÷ ¾ÆÀ̵ð¾î °ø¸ð (2019-06-03)
Digital Edge to Expand Platform Footprint in South Korea (2021-04-02)
±èÇý¿ø ÀÚÀÛ°î ¶óÀÌºê ÆÛÆ÷¸Õ½º ¡®È¸»ö µµ½Ã¡¯ (2020-07-24)
±³¿ø »¡°£Ææ, çÈ 2023 BETT ¾î¿öµå °á¼± ÁøÃâ (2023-01-31)
SKÅÚ·¹ÄÞ, µå·Ð¡¤AI ÅëÇØ Åë½Åž ¾ÈÀüµµ Á¡°Ë (2023-01-31)
±Ýõ±¸½Ã¼³°ü¸®°ø´Ü, ÆóÇö¼ö¸· ¾÷»çÀÌŬ¸µ (2022-01-05)
Áß±â Á÷ÀåÀÎ 84.3% ¿¬ºÀ ºÒ¸¸Á· (2021-04-28)
½Ö¿ëÂ÷, ±â¾÷ ȸ»ýÀýÂ÷ È¿À²Àû ÃßÁø (2021-04-28)
¼ÓÃÊÇ×¼­ ÄÚ½ºÅ¸ ¼¼·¹³ªÈ£ 3³â 8°³¿ù ¸¸¿¡ ù ÃâÇ× (2023-06-19)
»ï¼º¹°»ê, ·ç¸¶´Ï¾Æ ¼ÒÇü¸ðµâ¿øÀü °Ç¼³ Âü¿© (2023-06-19)
½ÅÇÑÄ«µå, ¡®Ä«Ä«¿À¹ðÅ© ½ÅÇÑÄ«µå¡¯ Ãâ½Ã (2020-04-28)
ÀÚÀ²ÁÖÇà Â÷·®¿ë 5³ª³ë ¹ÝµµÃ¼ »ý»ê Çù·Â (2023-02-26)
¸®µå½ºÇÇÄ¿ÄÚ¸®¾Æ, Ä¿½ºÅÒ º¸À̽º À§ÇÑ º¸À̽º·¦ (2020-06-19)
ºñÅõºñ ¼­Àº±¤, À¥Å÷ µµ±¼¿Õ OST ¡®³Ê¸¦ ¶°³ª¡¯ (2021-02-26)
LG»ýȰ°Ç°­, ¾÷¹« ·Îº¿ ¡®¾Ë ÆÄÆ®À塯 ä¿ë (2020-02-27)
½Å¹ß¿¡ ºÎ´Â ¡®±â´É¼º¡¯ ¹Ù¶÷ (2014-02-02)
ÆùŸ³ª, Àü±¹ À̸¶Æ® 83°³ ÁöÁ¡ ÄíŷŬ·¡½º ÁøÇà (2019-11-06)
SKÅÚ·¹ÄÞ, ¾çÀÚ¾ÏÈ£Åë½Å ±â¾÷ IDQ Àμö (2018-02-27)
SKÅÚ·¹ÄÞ, 5G ±â¹Ý»õ·Î¿î ¡®¾ÆÀÌÆù SE¡¯ Ãâ½Ã (2022-03-24)
Çö´ëȨ¼îÇÎ, Áß¼ÒÇù·Â»ç¿Í ¡®ÇϳëÀÌ ÇÑ·ù¹Ú¶÷ȸ¡¯ Âü°¡ (2022-12-01)
Çѱ¹ ´ëÇ¥±â¾÷ À̹ÌÁö, »ï¼º>LG>Çö´ëÂ÷>·Ôµ¥>CJ (2018-08-11)
ÀüÅ뿹¼ú º¹¿ø ¹× ÀçÇö ¡®ÀÚÀ¯ °úÁ¦¡¯ °ø¸ð (2020-04-19)
Áö¹æ ¼Ò¸ê ½Ã´ë... Á¤Ã¥ Àüȯ ÇÊ¿äÇÏ´Ù (2022-04-19)
À̰ø°è Àü°ø ´ëÇлý ¡®Â÷¼¼´ë Æ®·»µð »ê¾÷ JOB¾Æ¶ó!¡¯ (2023-04-19)
Çʸ®ÇÉ ¹× Àεµ³×½Ã¾Æ¿¡ ½ºÅ©·¯ºù ¼¾ÅÍ Ãß°¡ °³¼³ (2023-04-19)
       [ÀÌÀü][1]....[2675][2676][2677][2678][2679][2680][2681][2682][2683]...[3704][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..